miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 549, doi. 10.1093/carcin/bgad055
- By:
- Publication type:
- Article
Works matching IS 01433334 AND DT 2023 AND VI 44 AND IP 7
Results: 8
1
2
The current landscape of therapies for hepatocellular carcinoma.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 537, doi. 10.1093/carcin/bgad052
- By:
- Publication type:
- Article
3
RNA sequencing reveals the implication of the circRNA-associated ceRNA network in oesophageal squamous cell carcinoma.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 596, doi. 10.1093/carcin/bgad050
- By:
- Publication type:
- Article
4
PABPN1 promotes clear cell renal cell carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 576, doi. 10.1093/carcin/bgad049
- By:
- Publication type:
- Article
5
Depletion of Gr1<sup>+</sup> myeloid cells attenuates high-fat-diet-aggravated esophageal squamous cell carcinoma in mice.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 587, doi. 10.1093/carcin/bgad047
- By:
- Publication type:
- Article
6
Correction to: Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.
- Published in:
- 2023
- Publication type:
- Correction Notice
7
The ubiquitin E3 ligase MDM2 induces chemoresistance in colorectal cancer by degradation of ING3.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 562, doi. 10.1093/carcin/bgad040
- By:
- Publication type:
- Article
8
miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1/2 axis.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 7, p. 610, doi. 10.1093/carcin/bgad037
- By:
- Publication type:
- Article